key: cord-0923028-iezuikxb
authors: Duerr, G.D.; Heine, A.; Hamiko, M.; Zimmer, S.; Luetkens, J.A.; Nattermann, J.; Rieke, G.; Isaak, A.; Jehle, J.; Held, S.A.E.; Wasmuth, J.C.; Wittmann, M.; Strassburg, C.P.; Brossart, P.; Coburn, M.; Treede, H.; Nickenig, G.; Kurts, C.; Velten, M.
title: Parameters predicting COVID-19-induced myocardial injury and mortality()
date: 2020-09-09
journal: Life Sci
DOI: 10.1016/j.lfs.2020.118400
sha: ed4145d016c548ad9583655a7c992c9d528ed31a
doc_id: 923028
cord_uid: iezuikxb

Clinical manifestations of COVID-19 affect many organs, including the heart. Cardiovascular disease is a dominant comorbidity and prognostic factors predicting risk for critical courses are highly needed. Moreover, immunomechanisms underlying COVID-induced myocardial damage are poorly understood. OBJECTIVE: To elucidate prognostic markers to identify patients at risk. RESULTS: Only patients with pericardial effusion (PE) developed a severe disease course, and those who died could be identified by a high CD8/Treg/monocyte ratio. Ten out of 19 COVID-19 patients presented with PE, 7 (78%) of these had elevated APACHE-II mortality risk-score, requiring mechanical ventilation. At admission, PE patients showed signs of systemic and cardiac inflammation in NMR and impaired cardiac function as detected by transthoracic echocardiography (TTE), whereas parameters of myocardial injury e.g. high sensitive troponin-t (hs-TnT) were not yet increased. During the course of disease, hs-TnT rose in 8 of the PE-patients above 16 ng/l, 7 had to undergo ventilatory therapy and 4 of them died. FACS at admission showed in PE patients elevated frequencies of CD3(+)CD8(+) T cells among all CD3+ T-cells, and lower frequencies of Tregs and CD14(+)HLA(−)DR(+)-monocytes. A high CD8/Treg/monocyte ratio predicted a severe disease course in PE patients, and was associated with high serum levels of antiviral cytokines. By contrast, patients without PE and PE patients with a low CD8/Treg/monocyte ratio neither had to be intubated, nor died. CONCLUSIONS: PE predicts cardiac injury in COVID-19 patients. Therefore, TTE should be performed at admission. Immunological parameters for dysfunctional antiviral immunity, such as the CD8/Treg/monocyte ratio used here, supports risk assessment by predicting poor prognosis.

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has quickly progressed to a global pandemic health emergency, affecting various organs, and recent case reports associated myocardial involvement with poor prognosis [1] [2] [3] [4] . However, it has not been elucidated whether cardiac dysfunction and potential myocarditis is a primary result of SARS-CoV-2 induced cardiomyocyte damage or secondary to COVID-19 induced inflammation and the heart is the primary target or secondary bystander of disease 5 . Even though, autopsy studies have found evidence of direct myocyte assault by the virus, this was not associated with an influx of inflammatory cells 6 . Furthermore, studies investigating this potential link and identifying prognostic factors for cardiac injury and survival remain to be defined. Here, we correlated cardiac and immunologic parameters with clinical courses of COVID-19 patients to investigate potential mechanisms involved in the development of SARS-CoV-2 induced cardiac injury. Primary evaluation included transthoracic echocardiography (TTE), blood test and calculation of the APACHE II score ( Table 2 ). Data were recorded by our patient data management system. Routine serum diagnostics were measured. All patients were followed up until discharge or death.

Cardiac structure and function analyses TTE was performed using a Philips Affiniti with a 15 MHz probe (Philips, Germany). Left ventricular ejection fraction (EF) was calculated using the biplane method.

Cardiac magnetic resonance imaging Cardiac magnetic resonance imaging was performed using a clinical whole-body magnetic (Fig. 1A) . Seven of these PE patients subsequently developed respiratory failure and required invasive ventilatory support within 48hrs (Fig. 1B) . PE patients had higher APACHE II-scores (Fig.   1C ) and poorer survival (Fig. 1E ). Baseline characteristics, as well as pre-existing medical conditions did not differ between the groups (Table 1 ). In correlation with APACHE-scores, PE patients exhibited impaired left-ventricular EF (Table 1) . Cardiac magnetic resonance imaging revealed a diffuse inflammatory pattern with myocardial edema in PE patients, but no evidence for direct viral damage such as necrosis (Fig. 1D ). Cardiac inflammation was not detected in patients lacking PE. Myocardial damage marker such as hs-TnT increased only in PE patients during the course of disease (Fig. 1G ).

Next, we used flow-cytometry to identify inflammatory parameters that can predict at admission which of the PE patients would develop a severe disease course. This technique revealed normal frequencies of total leukocytes, lymphocytes and neutrophil blood counts in PE patients at admission (Table 1) . However, among the T cells, the frequencies of CD8 + T cells, important effectors of early antiviral immunity 7 , were increased, whereas regulatory T cells (Tregs), which control immune responses including CD8 + T cells [8] [9] [10] , and monocytes, which have been reported to accumulate at sites of Covid-19 infection and simultaneously disappear from the circulation 11 , were less frequent in PE patients ( Figure 2 ). We combined these 3 parameters altered in severely affected COVID-19 patients by calculating the CD8/Treg/monocyte ratio as a parameter for a dysfunctional antiviral immune response. Indeed, this ratio was low in all patients without PE and in three PE patients, and none of those developed a severe disease course (Fig. 1F) . The other PE patients showed a high CD8/Treg/monocyte ratio and developed an hs-TnT increase (Fig. 1G) , which correlated with the WHO COVID-19 classification (Fig. 1H) . These patients also showed high serum levels of pro-inflammatory cytokines (Fig. 1I-K) , consistent with the notion of a cytokine storm. Notably, an increase was seen also for the chemokine CCL2 (Fig. 1I) , which mobilizes blood monocytes, possibly to counteract monopenia. Four of the patients with a high CD8/Treg/monocyte ratio eventually died.

The present study addressed cardiac involvement in COVID-19 and provides clinical and molecular information on underlying immunomechanisms, thus supporting an association between (hyper)inflammation and myocardial damage. Myocardial involvement was evident in the form of a PE, long before serum markers of cardiomyocyte damage became significantly elevated. The PE was associated with a severe disease course, including respiratory failure and fatal outcome.

Consistent with previous reports of cardiac replication with SARS-CoV-2 in autopsy cases 6 , cardiac MRI revealed myocarditis in COVID19 patients with PE 12 , which was followed by elevated serum parameters cardiac damage, especially hs-TnT 2 . Further, we detected a reduced EF and increased markers of edema (T1 and T2 relaxation times) only in PE-patients. A recent report showed that recovered COVID-19 patients frequently showed signs of myocardial dysfunction in cardiac NMR 13 . Our findings are consistent with that report and demonstrate that inflammatory alterations of the heart are detectable already early in ongoing infection.

It has been speculated that an excessive immune response against COVID-19 might worsen cardiac dysfunction 14 . We here introduce the CD8/Treg/monocyte ratio to quantify an inadequate immune response that can target the heart. That ratio was low in all patients without PE and in those PE patients who survived, but high in patients who developed respiratory failure or died. Thus, a high CD8/Treg/monocyte ratio might serve as an early indicator for a severe cardiac involvement outcome in COVID-19, comparable to proteinuria recently shown to predict severe kidney involvement in this infection 15 . showing that a PE predicts poorer prognosis. (F): ratio between CD8 + T cells to Tregs and CD14 + HLA-DR + monocytes, as a parameter for disease severity, which was higher in patients with PE, especially in those who subsequently developed a hs-TnT rise (red symbols) and those who died 

Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019

Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes

Unexpected Features of Cardiac Pathology in COVID-19 Infection

The Heart in COVID19: Primary Target or Secondary Bystander? JACC Basic Transl Sci

Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases

HLA-class I-specific inhibitory receptors in HIV-1 infection

Increased expression of CD8 marker on T-cells in COVID-19 patients

Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19

Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges

Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages

Associated Myocarditis Detected by Multiparametric Cardiac Magnetic Resonance Imaging

Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease

COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options

Multiorgan and Renal Tropism of SARS-CoV-2

COVID-19 outbreak: less stethoscope, more ultrasound